Unit 3: Biosignaling

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/132

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

133 Terms

1
New cards

transduction

converts an extracellular signal to an intracellular response

<p>converts an extracellular signal to an intracellular response</p>
2
New cards

where can you find receptors

  • free floating in cytosol

  • nucleus

  • at cell membranes

3
New cards

ligand-gated channels are in either

open or close conformation

4
New cards

specificity

how many different ligands can bind to your receptor

5
New cards

sensitivity

how well the ligand binds to the receptor

  • you want a low Kd

6
New cards

avidity

summing responses using multiple binding sites, so that when one site lets go of the ligand, the next site binds to it

7
New cards

amplification

when each enzyme at a step activates many more enzymes

8
New cards

modularity

idea that one signal can cause multiple separate responses

9
New cards

integration

when different signals can form a combined response or cancel each other out

“crosstalk”

10
New cards

3 parts of G-proteins

alpha, gamma, beta

  • G-proteins bind guanine di or triphosphate (GDP or GTP)

  • Gs: stimulatory

  • Gi: inhibitory

11
New cards

glycogen breaks down into

glucose

12
New cards

3 types of biosignals

  • autocrine

  • paracrine

  • endocrine

13
New cards

4 major types of biosignaling systems

  • GPCR

  • receptor tyrosine kinase (and kinase cascades)

  • gated ion channel

  • nuclear receptor

14
New cards

signal transduction/cell signaling definition

the transmission of molecular signals from the environment that are not membrane permeable to the interior of the cell

15
New cards

things that cells can respond to

  • light

  • mechanical touch

  • neurotransmitters

  • nutrients

  • odorants

  • tastants

  • antigens

  • growth factors

  • hormones

  • glycoproteins/oligosaccharides

  • developmental signals

  • ECM components

16
New cards

changes that cell signals can evoke

  • differentiation and antibody production

  • growth in size, shape, or strength

  • gene expression

  • ability to divide (sexual or asexual reproduction)

17
New cards

autocrine signaling

acts on the cell the produced the signal

18
New cards

paracrine signaling

localized signaling to a nearby cell

19
New cards

endocrine signaling

distant signaling through the bloodstream using hormones

20
New cards

the binding of a signal to the receptor causes

the receptor to change in some way, usually a shape change (induced fit occurs)

  • this initiates a downstream response

21
New cards

if a receptor is free floating, it must be able to

get to the plasma membrane on its own

22
New cards

examples of each main type of receptor

GPCR: epinephrine receptor

enzyme-linked: insulin receptor

ligand-gated: nicotinic ACh receptors

nuclear: steroid receptors

other membrane: integrin receptors (for cell crawling/attachment)

23
New cards

the human genome has _____ GPCRs and we have _____ drugs that target them

>800

>700 drugs to target them

24
New cards

20% of all cancers are due to a mutation in

GPCR genes

25
New cards

about ____% of drugs target GPCRs

25

26
New cards

GPCR drugs can treat

hypertension, drug abuse, mental health, asthma, etc

27
New cards

types of receptors often targeted by drugs

  • GPCR

  • enzyme-linked

  • ion channels

  • others

28
New cards

desensitization

turning off a pathway

29
New cards

integration

when two signals have opposite or summing effects to create a response

30
New cards

divergence

when a receptor gets activated and activates two different pathways taht have different end effects

31
New cards

localized responseq

when the enzyme that destroys an intracellular message is clustered with the message producer, so that the message is degraded before it can diffuse to distant targets, creating a brief and local response only

32
New cards

typical ligands

  • small ions

  • organic molecules

  • polysaccharides

  • peptides

  • proteins

33
New cards

what Kd values show a high affinity of receptors for their signal molecule/

10^-7 or less

34
New cards

cooperativity

how well binding at one site influences binding at another site

35
New cards

clutsering

  • can use lipid rafts or maybe things are just in close proximity to speed up rxns

36
New cards

avidity

when one receptor releases its ligand and the next immediately binds that same ligand, combining affinity for an immediate response

37
New cards

every cell expresses different proteins, so

they respond to the same signal in different ways

38
New cards

crosstalk

integration of multiple signals

39
New cards

parts of a GPCR

  • receptor is transmembrane and has 7 alpha helices through it

  • ligand binds to the receptor

  • this activates a G-protein, which regulates an enzyme

<ul><li><p>receptor is transmembrane and has 7 alpha helices through it</p></li><li><p>ligand binds to the receptor</p></li><li><p>this activates a G-protein, which regulates an enzyme</p></li></ul><p></p>
40
New cards

receptor tyrosine kinase

ligand binding activates a tyrosine kinase by autophosphorylation, causing a kinase cascade, eventually altering gene expression

<p>ligand binding activates a tyrosine kinase by autophosphorylation, causing a kinase cascade, eventually altering gene expression</p>
41
New cards

gated ion channel

ligand goes through the channel and binds to a protein, altering gene expression

<p>ligand goes through the channel and binds to a protein, altering gene expression</p>
42
New cards

GPCRs are _____

heterotrimeric membrane-associated proteins

  • have alpha, gamma, and beta subunits

  • the receptor changes shape when the ligand binds

<p>heterotrimeric membrane-associated proteins</p><ul><li><p>have alpha, gamma, and beta subunits</p></li><li><p>the receptor changes shape when the ligand binds</p></li></ul><p></p>
43
New cards

epinephrine

aka adrenaline

  • made in the adrenal glands on top of the kidneys and is secreted thru the bloodstream as an endocrine signal

  • mediates the stress/sympathetic response

  • binds to receptors in muscle and liver cells to initiate breakdown of glycogen for energy

  • also binds to receptors in adipose cells to induce lipid hydrolysis

  • also binds receptors in heart cells to incr HR

<p>aka adrenaline</p><ul><li><p>made in the adrenal glands on top of the kidneys and is secreted thru the bloodstream as an endocrine signal</p></li><li><p>mediates the stress/sympathetic response</p></li><li><p>binds to receptors in muscle and liver cells to initiate breakdown of glycogen for energy</p></li><li><p>also binds to receptors in adipose cells to induce lipid hydrolysis</p></li><li><p>also binds receptors in heart cells to incr HR</p></li></ul><p></p>
44
New cards

which subunits of the G-protein in a GPCR are lipid anchored?

gamma and alpha

<p>gamma and alpha</p>
45
New cards

steps of GPCR activation

  • ligand (like epinephrine) binds to the beta-adrenergic receptor of the GPCR

  • the GPCR undergoes a shape change, and the GDP bound to the alpha subunit of the G-protein gets replaced with a GTP

  • alpha separates from beta gamma and activates adenylyl cyclase (the enzyme and effector)

  • adenylyl cyclase (AC) converts ATP to cAMP

  • cAMP activates PKA, which phosphorylates proteins causing a cellular response

  • cyclic nucleotide phosphodiesterase cleaves cAMP to form AMP so no more PKA gets activated

<ul><li><p>ligand (like epinephrine) binds to the beta-adrenergic receptor of the GPCR</p></li><li><p>the GPCR undergoes a shape change, and the GDP bound to the alpha subunit of the G-protein gets replaced with a GTP</p></li><li><p>alpha separates from beta gamma and activates adenylyl cyclase (the enzyme and effector)</p></li><li><p>adenylyl cyclase (AC) converts ATP to cAMP</p></li><li><p>cAMP activates PKA, which phosphorylates proteins causing a cellular response</p></li><li><p>cyclic nucleotide phosphodiesterase cleaves cAMP to form AMP so no more PKA gets activated</p></li></ul><p></p>
46
New cards

which two subunits of the g-protein in a GPCR are always together

beta and gamma

47
New cards

what causes the shape change of the alpha g-protein subunit

when GDP is exchanged for GTP

  • this is what causes the alpha to dissociate from beta gamma

48
New cards

Galpha subunit activity

  • active when GTP bound

    • the switches of the protein face in to keep the P inside

  • inactive when GDP bound

    • switches face out so the P can leave the protein to bind a new GTP

    • when the P leaves it can interact with beta gamma

<ul><li><p>active when GTP bound</p><ul><li><p>the switches of the protein face in to keep the P inside</p></li></ul></li><li><p>inactive when GDP bound</p><ul><li><p>switches face out so the P can leave the protein to bind a new GTP</p></li><li><p>when the P leaves it can interact with beta gamma</p></li></ul></li></ul><p></p>
49
New cards

intrinsic rate of hydrolysis

when the last P leaves the Galpha protein after it binds a new GTP

50
New cards

cyclic nucleotide phosphodiesterase

enzyme that cleaves cAMP to form AMP

<p>enzyme that cleaves cAMP to form AMP</p>
51
New cards

adenylyl cyclase (AC)

converts ATP to cAMP when activated by Galpha

<p>converts ATP to cAMP when activated by Galpha</p>
52
New cards

cAMP is a common

secondary messenger

  • causes a quick response

53
New cards

many GPCRs mediate their effects via

cAMP (using Gs or Gi)

54
New cards

cAMP _____ activates PKA (cAMP-dependent protein kinase A)

allosterically

55
New cards

cAMP-dependent protein kinase A

PKA

  • when activated by/bound to cAMP, activates other enzymes that produce glucose from glycogen

56
New cards

cAMP being converted into AMP

adenosine-monophosphate

  • the location of the P changes since a bond it was attached to got cleaved

<p>adenosine-monophosphate</p><ul><li><p>the location of the P changes since a bond it was attached to got cleaved</p></li></ul><p></p>
57
New cards

what does PKA need in order to be functional

have cAMP bound to it

58
New cards

protein kinases

add Ps to things, typically

  • Ser

  • Thr

  • Tyr

    • since these all have OH’s, which are easily phsophorylated

59
New cards

protein kinases differ in

the target proteins that they recognize

  • depends on the AA sequence of the target protein that the kinases recognizes

60
New cards

in the cAMP pathway, cAMP molecules diffuse into the _____

cytoplasm, where they bind to and activate PKAs

  • two cAMP bind to each regulatory protein of the PKA complex

  • once bound, this causes a shape change so that the two catalytic proteins of the complex can dissociate from the regulatory subunits and bind to something downstream (often activates proteins to trigger breaking down of glycogen in the liver for the sympathetic/ fight or flight response

<p>cytoplasm, where they bind to and activate PKAs</p><ul><li><p>two cAMP bind to each regulatory protein of the PKA complex</p></li><li><p>once bound, this causes a shape change so that the two catalytic proteins of the complex can dissociate from the regulatory subunits and bind to something downstream (often activates proteins to trigger breaking down of glycogen in the liver for the sympathetic/ fight or flight response</p></li></ul><p></p>
61
New cards

PKAs can do many different things in

diff cell types

<p>diff cell types</p>
62
New cards

scaffold/anchoring proteins

cluster signaling proteins together to incr the rate of rxn

  • this localization of PKA via anchoring proteins, for example, allows cAMP to mediate multiple signals at once

  • diff anchors are expressed in diff cell types, so changes the downstream affect of cAMP in diff cell types

<p>cluster signaling proteins together to incr the rate of rxn</p><ul><li><p>this localization of PKA via anchoring proteins, for example, allows cAMP to mediate multiple signals at once</p></li><li><p>diff anchors are expressed in diff cell types, so changes the downstream affect of cAMP in diff cell types</p></li></ul><p></p>
63
New cards

amplification in GPCRs

  • activation of just a few GPCRs can activate a few adenylyl cyclases which convert MANY ATP into cAMP

  • but it takes two cAMP to activate one catalytic subunit of PKA

  • then some PKA activates MANY kinases

  • then tens of thousands of glucose molecules can eventually get released into the bloodstream from the liver

<ul><li><p>activation of just a few GPCRs can activate a few adenylyl cyclases which convert MANY ATP into cAMP</p></li><li><p>but it takes two cAMP to activate one catalytic subunit of PKA</p></li><li><p>then some PKA activates MANY kinases</p></li><li><p>then tens of thousands of glucose molecules can eventually get released into the bloodstream from the liver</p></li></ul><p></p>
64
New cards

diff cells can express diff ____, which bind the same ligand/hormone

GPCRs

  • hormone receptor-mediated responses regulated by G-proteins can be stimulatory or inhibitory since each hormone receptor specifically interacts with either a Gs or Gi protein

  • activation of Gi proteins can reduce signaling

  • basically GPCRs can use Gi or Gs proteins, therefore shutting down a pathway or stimulating one

<p>GPCRs</p><ul><li><p>hormone receptor-mediated responses regulated by G-proteins can be stimulatory or inhibitory since each hormone receptor specifically interacts with either a Gs or Gi protein</p></li><li><p>activation of Gi proteins can reduce signaling</p></li><li><p>basically GPCRs can use Gi or Gs proteins, therefore shutting down a pathway or stimulating one</p></li></ul><p></p>
65
New cards

epinephrine is a ___ signal

short-acting

  • uses desensitization to turn off a pathway once it is no longer needed

    • ex: stopping glucose synthesis once the fight/flight response is no longer needed

66
New cards

turning off GPCR pathways via self-inactivation

  • pathway could be inactivated by lowering the [ligand]

  • but it is typically regulated by:

    • cyclic nucleotide phosphodiesterase converting cAMP into AMP, so there is less cAMP to activate PKAs

    • Galpha has intrinsic rate of hydrolysis, so it switches out its GTP for a GDP after a while (certain amount of time like a timer), and binding the GDP inactivates the pathway by down regulating cAMP levels since when Galpha binds GDP, it can no longer activate adenylyl cyclase to make cAMP

<ul><li><p>pathway could be inactivated by lowering the [ligand]</p></li><li><p>but it is typically regulated by:</p><ul><li><p>cyclic nucleotide phosphodiesterase converting cAMP into AMP, so there is less cAMP to activate PKAs</p></li><li><p>Galpha has intrinsic rate of hydrolysis, so it switches out its GTP for a GDP after a while (certain amount of time like a timer), and binding the GDP inactivates the pathway by down regulating cAMP levels since when Galpha binds GDP, it can no longer activate adenylyl cyclase to make cAMP</p></li></ul></li></ul><p></p>
67
New cards

GEFs

guanine exchange factors

  • switch GDP for a GTP

  • usually activating but not always

  • ex: GPCR receptor binds ligand and then changes its shape so that alpha can bind GTP (the GPCR is the GEF)

<p>guanine exchange factors</p><ul><li><p>switch GDP for a GTP</p></li><li><p>usually activating but not always</p></li><li><p>ex: GPCR receptor binds ligand and then changes its shape so that alpha can bind GTP (the GPCR is the GEF)</p></li></ul><p></p>
68
New cards

GAPs

  • GTPase activating proteins

  • switch GTPs for GDPs

  • usually inactivating

<ul><li><p>GTPase activating proteins</p></li><li><p>switch GTPs for GDPs</p></li><li><p>usually inactivating</p></li></ul><p></p>
69
New cards

beta-adrenergic receptors to turn off the GPCR pathway (desensitization)

  • you can tell a pathway has been on bc beta and gamma G-proteins have been together for a while (so alpha must be bound to GTP and to adenylyl cyclase, keeping the pathway on) (also the ligand epinephrine is bound to the GPCR)

  • so BARK (beta-adrenergic receptor kinase) gets recruited and adds a P to the GPCR, creating a binding site

  • these binding sites allow beta-arrestin to bind, which initiates exocytosis at the membrane so that GPCRs are taken into the cell in a vesicle

  • this decr rate of rxn for the pathway since the receptors were taken away 

<ul><li><p>you can tell a pathway has been on bc beta and gamma G-proteins have been together for a while (so alpha must be bound to GTP and to adenylyl cyclase, keeping the pathway on) (also the ligand epinephrine is bound to the GPCR)</p></li><li><p>so BARK (beta-adrenergic receptor kinase) gets recruited and adds a P to the GPCR, creating a binding site</p></li><li><p>these binding sites allow beta-arrestin to bind, which initiates exocytosis at the membrane so that GPCRs are taken into the cell in a vesicle</p></li><li><p>this decr rate of rxn for the pathway since the receptors were taken away&nbsp;</p></li></ul><p></p>
70
New cards

agonists

structural analogs of ligands that bind to a GPCR receptor to keep the pathway going (mimics the ligand)

  • usually are drugs

71
New cards

antagonists

structural analogs of ligands that bind to a GPCR receptor so that the ligand cannot bind (the drug has very low Kd), and inhibits the pathway

  • often are drugs

72
New cards

morphine

an agonist of certain opioid receptors

  • therefore relieves pain since it causes feelings that combat the feeling of pain

73
New cards

opioid receptors in the body are often

GPCRs

  • GPCRs can bind to natural hormones such as endorphins and cause physiological affects like runner’s high, euphoria, respiratory depression

  • happens when mu-opioid receptor (a GPCR) gets signals and then causes downstream affects that cause good feelings (which combat the feelings of pain)

<p>GPCRs</p><ul><li><p>GPCRs can bind to natural hormones such as endorphins and cause physiological affects like runner’s high, euphoria, respiratory depression</p></li><li><p>happens when mu-opioid receptor (a GPCR) gets signals and then causes downstream affects that cause good feelings (which combat the feelings of pain)</p></li></ul><p></p>
74
New cards

what is bad about GPCR opioid receptors?

the receptors can become desensitized if they are constantly receiving ligand/drug/hormone

  • this causes drug resistance and eventually addiction

75
New cards

second messengers

  • cAMP

  • IP3

  • DAG (diacylgylcerol)

76
New cards
  • hormone binds to a GPCR

  • alpha activated, interacts with an effector (phospholipase C) (PLC)

  • PLC’s substrate is pip2, a phospholipid

  • PLC cleaves polar head groups and phosphate of the glycerophospholipid (pip2)

  • the glycerophospholipid had an inositol head group, and once cleaved, it forms IP3

  • the remaing glycerol backbone with two FA chains forms DAG (diacylgylcerol)

  • DAG and IP3 are both secondary messengers

  • DAG stays in membrane due to its FAs, it diffuses out laterally through the membrane and interacts with protein kinase C (but DAG alone cannot activate protein kinase C)

  • IP3 binds to receptor-gated Ca2+ channel in ER membrane, causing gate to open and Ca2+ leaves ER

  • the Ca2+ also binds protein kinase C

  • now protein kinase C is fully activated

<ul><li><p>hormone binds to a GPCR </p></li><li><p>alpha activated, interacts with an effector (phospholipase C) (PLC)</p></li><li><p>PLC’s substrate is pip2, a phospholipid</p></li><li><p>PLC cleaves polar head groups and phosphate of the glycerophospholipid (pip2)</p></li><li><p>the glycerophospholipid had an inositol head group, and once cleaved, it forms IP3 </p></li><li><p>the remaing glycerol backbone with two FA chains forms DAG (diacylgylcerol)</p></li><li><p>DAG and IP3 are both secondary messengers</p></li><li><p>DAG stays in membrane due to its FAs, it diffuses out laterally through the membrane and interacts with protein kinase C (but DAG alone cannot activate protein kinase C)</p></li><li><p>IP3 binds to receptor-gated Ca2+ channel in ER membrane, causing gate to open and Ca2+ leaves ER</p></li><li><p>the Ca2+ also binds protein kinase C</p></li><li><p>now protein kinase C is fully activated</p></li></ul><p></p>
77
New cards

DAG and IP3 are ____ secondary messengers

lipid

  • so both are membrane permeable

78
New cards

activated effectors often generate

secondary messengers

79
New cards

aspects of one pathway can influence another

crosstalk

<p>crosstalk</p>
80
New cards

when are G-proteins activated?

when the GDP leaves and a new GTP binds to the Galpha protein

81
New cards

there are many categories of

enzyme-linked membrane receptors

  • can require one or two ligands

82
New cards

receptor tyrosine kinase activation

  • ligand binds to each of the two polypeptide receptors

  • the two receptors dimerize and cross phosphorylate each other at their tyrosine residues from ATP

  • the phosphates on the catalytic domains can serve as docking sites for downstream proteins

    • the receptors are formed or an extracellular ligand-binding domain and an intracellular catalytic domain

<ul><li><p>ligand binds to each of the two polypeptide receptors</p></li><li><p>the two receptors dimerize and cross phosphorylate each other at their tyrosine residues from ATP</p></li><li><p>the phosphates on the catalytic domains can serve as docking sites for downstream proteins</p><ul><li><p>the receptors are formed or an extracellular ligand-binding domain and an intracellular catalytic domain</p></li></ul></li></ul><p></p>
83
New cards

in tyrosine kinases, each receptor needs its own

ligand bound 

84
New cards

once receptor tyrosine kinases (RTKs) are dimerized but not yet cross-phosphorylated, enzymatic activity…

incr a little bit so that they can cross-phosphorylate each other

  • so most RTK catalytic domains have low intrinsic kinase activity

85
New cards

one activated RTK dimer can activate

10 or more different intracellular proteins simultaneously

  • which can cause many diff responses

86
New cards

RTK pathways are especially helpful for

when a cell needs to regulate and coordinate a variety of pathways at once

87
New cards

IRS-1

a target protein for RTKs

  • insulin-receptor substrate-1

  • once the RTK gets phosphorylated, IRS-1 can bind to the P docking sites and can itself become a docking site for other proteins

88
New cards

the phosphorylated tyrosines of RTKs bind to ___ domains on target proteins

  • SH2

  • PTB (phospho-tyrosine binding) domain

  • these two types of domains are domains of target proteins that bind to the Ps of the RTKs

  • they have similar tertiary structure

  • SH2 and PTB can couple activated RTKs to downstream components of signal pathways

<ul><li><p>SH2</p></li><li><p>PTB (phospho-tyrosine binding) domain</p></li><li><p>these two types of domains are domains of target proteins that bind to the Ps of the RTKs</p></li><li><p>they have similar tertiary structure</p></li><li><p>SH2 and PTB can couple activated RTKs to downstream components of signal pathways</p></li></ul><p></p>
89
New cards

proteins that only bind to RTK when the RTK is phosphorylated have certain

domains that bind to the P

  • SH2 or PTB binding domains

90
New cards

phosphatases

remove phosphates

  • the opposite of kinases

91
New cards

examples of some second messengers

  • IP3

  • DAG

  • Ca2+

  • cAMP

92
New cards

phosphodiesterases

enzymes that break down second messengers

93
New cards

insulin is secreted in response to 

high blood glucose

  • it is released from the pancreas and goes to liver, fat, and muscle cells by traveling through the bloodstream

94
New cards

diabetes

the inability to make or sense insulin

  • due to either a faulty receptor or an inability to produce insulin

95
New cards

binding of insulin to the insulin receptor causes

a cascade of events that lead to incr glu uptake and metabolism

96
New cards

RTKs are made up of _____ and ____ proteins

alpha and beta

  • one of each

  • but RTKs can vary in shape a lot

<p>alpha and beta</p><ul><li><p>one of each</p></li><li><p>but RTKs can vary in shape a lot</p></li></ul><p></p>
97
New cards

insulin receptor structure

  • is an RTK and the ligand binds to one of the extracellular proteins of the receptor

  • once L binds, the two intracellular proteins move closer to each other and then phosphorylate each other

  • this phosphorylation at the tyrosines on the protein intracellular random coil causes the active site of the intracellular domains to open up, as the Tyr are no longer covering it

    • before the random coil with the Tyr’s was covering the active site

  • the P’d Tyr’s can serve as docking sites for SH2 and PTB binding domains

<ul><li><p>is an RTK and the ligand binds to one of the extracellular proteins of the receptor</p></li><li><p>once L binds, the two intracellular proteins move closer to each other and then phosphorylate each other</p></li><li><p>this phosphorylation at the tyrosines on the protein intracellular random coil causes the active site of the intracellular domains to open up, as the Tyr are no longer covering it</p><ul><li><p>before the random coil with the Tyr’s was covering the active site</p></li></ul></li><li><p>the P’d Tyr’s can serve as docking sites for SH2 and PTB binding domains</p></li></ul><p></p>
98
New cards

Insulin pathway to signal for GLUT 4 transporter production

  • insulin binds to the insulin receptor, which autophosphorylates itself at its Tyr residues

  • the receptor then Ps the IRS1 on its Tyr residues, so the IRS1 basically docks into the Tyrs

  • The SH2 domain of Grb2 (scaffold protein) binds to the P’d Tyr of IRS1 (so Brb2 brings IRS1 and Sos tg)

  • Sos binds to Grb2 and acts as a GEF to switch out Ras’s GDP for a GTP

  • so Sos activates Ras 

  • activated Ras binds to Raf-1, which acts as a kinase to phosphorylate MEK on its two Ser residues

  • MEK is also a kinase and Ps ERK at its Thr and Tyr

  • ERK goes into the nucleus and Ps and activates a TF, Elk1, which can now associate with another TF, SRF and cause expression of GLUT4 transporter genes

<ul><li><p>insulin binds to the insulin receptor, which autophosphorylates itself at its Tyr residues</p></li><li><p>the receptor then Ps the IRS1 on its Tyr residues, so the IRS1 basically docks into the Tyrs</p></li><li><p>The SH2 domain of Grb2 (scaffold protein) binds to the P’d Tyr of IRS1 (so Brb2 brings IRS1 and Sos tg)</p></li><li><p>Sos binds to Grb2 and acts as a GEF to switch out Ras’s GDP for a GTP</p></li><li><p>so Sos activates Ras&nbsp;</p></li><li><p>activated Ras binds to Raf-1, which acts as a kinase to phosphorylate MEK on its two Ser residues</p></li><li><p>MEK is also a kinase and Ps ERK at its Thr and Tyr</p></li><li><p>ERK goes into the nucleus and Ps and activates a TF, Elk1, which can now associate with another TF, SRF and cause expression of GLUT4 transporter genes</p></li></ul><p></p>
99
New cards

____ is the point of nucleation for many other proteins in the insulin pathway

IRS1

100
New cards

Grb is a ____ protein

scaffold/ adaptor

  • it also has a SH2 domain, allowing it to bind to IRS1

  • Grb2 brings IRS1 and Sos tg